anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Alkermes · research-note

Alkermes | Investor Presentation Deck | 32 slides

32 pages · 5 arc beats · 3 loops

Research-Note Download JSON
Unlock

Alkermes | Investor Presentation Deck | 32 slides

Alkermes · 2023-03
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 17 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Situation & Context 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Problem & Complication 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides · 2 hits 100% 1/1 slides Solution & Approach 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Evidence & Proof 13 slides 100% 13/13 slides 100% 13/13 slides · 55 hits
— 0/13 slides
23.1% 3/13 slides
— 0/13 slides
100% 13/13 slides · 14 hits 30.8% 4/13 slides Impact & Next Steps 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides

Slide inventory

32
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
front_matter
Open slide detail
03
Hub-and-spoke diagram showing core business pillars.establish_context
Open slide detailBeat · Situation & ContextLoop · Golden Circle
04
The slide uses a hub-and-spoke diagram to show the core Alkermes business assets and the spin-off oncology business.present_solution
Open slide detailBeat · Solution & ApproachLoop · Golden Circle
05
prioritize
Open slide detailBeat · Impact & Next StepsLoop · Golden Circle
06
transition
Open slide detail
07
Includes a boxed warning disclaimer at the bottom.establish_context
Open slide detail
08
The chart shows a steady upward trend in weekly total prescriptions (TRx) over 73 weeks.analyze_data
Open slide detailBeat · Evidence & Proof
09
The slide uses a comparison table structure to quantify the market opportunity for two distinct indications.size_opportunity
Open slide detailBeat · Evidence & Proof
10
The slide combines a treatment indication matrix with a donut chart illustrating patient symptom prevalence.analyze_data
Open slide detailBeat · Evidence & Proof
11
The slide includes a mandatory boxed warning disclaimer at the bottom.other
Open slide detailBeat · Evidence & Proof
12
analyze_data
Open slide detailBeat · Evidence & Proof
13
Includes product branding, dosage options, and a bar chart showing revenue growth.analyze_data
Open slide detailBeat · Evidence & Proof
14
Includes a callout regarding COVID-19 impact on 2020 sales.analyze_data
Open slide detailBeat · Evidence & Proof
15
analyze_data
Open slide detailBeat · Evidence & Proof
16
transition
Open slide detailBeat · Evidence & Proof
17
Includes a medical illustration of brain pathways related to wakefulness and neurotransmitters.diagnose_problem
Open slide detailBeat · Problem & ComplicationLoop · Cost Of Inaction
18
Includes a molecular visualization of the Orexin 2 receptor.present_solution
Open slide detailBeat · Evidence & ProofLoop · Cost Of Inaction
19
Data presented as Mean ± SEM; One-way ANOVA used for statistical significance.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Cost Of Inaction
20
The heatmaps visualize EEG frequency power over time, with red indicating high power (arousal) and blue indicating low power.analyze_data
Open slide detailBeat · Evidence & ProofLoop · Cost Of Inaction
21
The slide uses a process flow diagram to show the progression of clinical trials.plan_implementation
Open slide detailLoop · Quick Win Big Bet
22
The slide outlines a two-stage clinical development process with specific objectives and assessment criteria for each phase.plan_implementation
Open slide detailLoop · Quick Win Big Bet
23
transition
Open slide detail
24
The slide outlines the core assets (nemvaleukin alfa, IL-12, IL-18) and the strategic rationale for a spin-off.summarize
Open slide detail
25
The slide uses a human body diagram to map clinical responses (CR, PR, uPR) across various cancer types.summarize
Open slide detail
26
The slide uses a matrix-like layout to categorize studies by 'Potential Registration Enabling Studies' and 'Alternative Dosing Studies'.plan_implementation
Open slide detail
27
transition
Open slide detail
28
The slide outlines the strategic rationale for a spin-off, emphasizing focus and profitability.summarize
Open slide detail
29
The chart illustrates the shift from a single-product revenue base to a more diversified portfolio including VIVITROL, ARISTADA, VUMERITY, and LYBALVI.analyze_data
Open slide detail
30
Includes disclaimer regarding non-GAAP reconciliation and specific business context (oncology spin-off, INVEGA royalties).summarize
Open slide detail
31
prioritize
Open slide detail
32
closing_ask
Open slide detail